Latest Stock/Share Market Updates | Corporate News | Announcements | BSE
BSE Buyback Notices Media Release Trading Holidays BSEPlus Contact Us
हिन्दी     मराठी     ગુજરાતી


Latest Corporate Announcements

Announcement Type :   Search By :    
Security Name
Category
Date Calendar
To Date Calendar
Disclaimer  Next >>
   
Security Code : 532488    Company : DIVI'S LABORATORIES LTD.
11 Apr 2018
Shareholding for the Period Ended March 31, 2018Company Update 
  Exchange Disseminated Time     11/04/2018 10:42:05
Divis Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click here
 
09 Apr 2018
  Statement Of Investor Complaints For The Quarter Ended March 2018Company Update Download XBRL
  Exchange Received Time  09/04/2018 09:47:54         Exchange Disseminated Time   09/04/2018 09:48:00              Time Taken   00:00:06
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
011110
Name of the Signatory :- P.V. Lakshmi Rajani
Designation :- Company Secretary and Compliance Officer
07 Apr 2018
Compliance Certificate For The Period Ended 31St March 2018Company UpdateDownload PDFDownload XBRL
  Exchange Received Time  07/04/2018 10:09:12         Exchange Disseminated Time   07/04/2018 10:09:20              Time Taken   00:00:08
Compliance Certificate certifying compliance with the requirements of sub-regulation (2), from the Company and the Registrar and Share Transfer Agent for the period ended 31st March 2018
 
06 Apr 2018
Compliance Certificate Under Regualtion 40(10)Of SEBI Listing Regulations Company UpdateDownload PDFDownload XBRL
  Exchange Received Time  06/04/2018 12:29:18         Exchange Disseminated Time   06/04/2018 12:29:26              Time Taken   00:00:08
Please find enclosed Compliance Certificate as required under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the year ended 31st March 2018.
 
27 Jan 2018
  Financial Results For December 31, 2017ResultDownload PDFDownload XBRL
  Exchange Received Time  27/01/2018 17:40:32         Exchange Disseminated Time   27/01/2018 17:40:39              Time Taken   00:00:07
Further to our letter dated 18th January, 2018, we would like to inform that the Board of Directors of the Company at its meeting held on Saturday, 27th January 2018 has approved Un-audited Financial Results for the quarter and nine months ended 31st December, 2017.

In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we are enclosing herewith the following: ....
18 Jan 2018
  Board Meeting On January 27, 2018Board MeetingDownload PDFDownload XBRL
  Exchange Received Time  18/01/2018 16:01:03         Exchange Disseminated Time   18/01/2018 16:01:13              Time Taken   00:00:10
Notice is hereby given that a meeting of Board of Directors of the Company is scheduled to be held on Saturday, the 27th day of January 2018 to consider and approve, inter-alia, the un-audited financial results for the quarter and nine months ended 31st December 2017.

We further inform you that the Trading Window for dealing in securities of the Company shall remain closed for insiders of the company from January 20, 2018 to January 29, ....
10 Jan 2018
  Statement Of Investor Complaints For The Quarter Ended 31St December 2017.Company UpdateDownload PDFDownload XBRL
  Exchange Received Time  10/01/2018 12:44:09         Exchange Disseminated Time   10/01/2018 12:44:15              Time Taken   00:00:06
In compliance with Regulation 13 (3) of SEBI (LODR) Regulations, 2015, please find below the statement of investors complaints for the quarter ended 31st December, 2017:

S.No. Particulars Number
1 Number of complaints pending at the beginning of the quarter Nil
2 Number of complaints received during the quarter 14
3 Number of complaints disposed of during the quarter 14
4 Number of complaints remaining unresolved at the end
of the quarter Nil


Shareholding for the Period Ended December 31, 2017Company Update 
  Exchange Disseminated Time     10/01/2018 12:32:39
Divis Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click here
 
18 Nov 2017
UpdatesCompany UpdateDownload PDFDownload XBRL
  Exchange Received Time  18/11/2017 12:06:27         Exchange Disseminated Time   18/11/2017 12:06:34              Time Taken   00:00:07
We had earlier informed the Exchanges that the company's Unit-II at Visakhapatnam was inspected by US-FDA in September, 2017 wherein a Form-483 was issued with 6 observations.

In this regard, we wish to inform you that we have now received an Establishment Inspection Report (EIR) from US-FDA for our Unit-II, as closure of audit by FDA.
 
15 Nov 2017
UpdatesCompany UpdateDownload PDFDownload XBRL
  Exchange Received Time  15/11/2017 08:45:05         Exchange Disseminated Time   15/11/2017 08:45:09              Time Taken   00:00:04
We had earlier informed the Exchanges vide our letter of 2nd November, 2017 that the US-FDA will be lifting the Import Alert 66-40 imposed on the company's Unit-II at Visakhapatnam.

The FDA's website has now been updated on 14th November, 2017 and the Import Alert 66-40 on the company's Unit-II has been removed
 
10 Nov 2017
UpdatesCompany UpdateDownload PDFDownload XBRL
  Exchange Received Time  10/11/2017 09:04:59         Exchange Disseminated Time   10/11/2017 09:05:03              Time Taken   00:00:04
Further to our letter dated 2nd November, 2017, Divi's Laboratories has been informed by the US-FDA that the Agency has completed evaluation of the Company's corrective actions in response to FDA's Warning Letter: 320-17-34 dated April 13, 2017. We also note from the update on FDA's website that they have closed-out the warning letter.
 
02 Nov 2017
UpdatesCompany UpdateDownload PDFDownload XBRL
  Exchange Received Time  02/11/2017 08:36:44         Exchange Disseminated Time   02/11/2017 08:36:50              Time Taken   00:00:06
Divi's Laboratories has been informed by the US-FDA that it will be lifting the Import Alert 66-40 and moving to close out the Warning letter issued to the company's Unit-II at Visakhapatnam.
 
31 Oct 2017
  Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2017ResultDownload PDFDownload XBRL
  Exchange Received Time  31/10/2017 18:41:59         Exchange Disseminated Time   31/10/2017 18:42:01              Time Taken   00:00:02
Further to our letter dated 20th October, 2017, we would like to inform that the Board of Directors of the Company at its meeting held on Tuesday, 31st October 2017 has approved Un-audited Financial Results for the quarter and half-year ended 30th September, 2017.

In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we are enclosing herewith the following: ....
20 Oct 2017
  Board Meeting On 31St October, 2017Board MeetingDownload PDFDownload XBRL
  Exchange Received Time  20/10/2017 11:06:08         Exchange Disseminated Time   20/10/2017 11:06:15              Time Taken   00:00:07
Notice is hereby given that a meeting of Board of Directors of the Company is scheduled to be held on Tuesday, the 31st day of October 2017 to consider and approve, inter-alia, the un-audited financial results for the quarter and half-year ended 30th September 2017.

We further inform you that the Trading Window for dealing in securities of the Company shall remain closed for insiders of the company from October 24, 2017 to November 2, 2017 ....
16 Oct 2017
Compliance Certificate For The Half Year Ended 30Th September, 2017Company UpdateDownload PDFDownload XBRL
  Exchange Received Time  16/10/2017 15:08:05         Exchange Disseminated Time   16/10/2017 15:08:14              Time Taken   00:00:09
Please find enclosed Compliance Certificate as required under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the half year ended 30th September 2017.
 
10 Oct 2017
Shareholding for the Period Ended September 30, 2017Company Update 
  Exchange Disseminated Time     10/10/2017 14:36:32
Divis Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click here
 
09 Oct 2017
Compliance Certificate For The Period Ended 30Th September, 2017Company UpdateDownload PDFDownload XBRL
  Exchange Received Time  09/10/2017 12:24:05         Exchange Disseminated Time   09/10/2017 12:24:09              Time Taken   00:00:04

We enclose herewith Compliance Certificate certifying compliance with the requirements of sub-regulation (2), from the Company and the Registrar and Share Transfer Agent for half year ended 30th September 2017
 
  Statement Of Investor Complaints For The Quarter Ended 30Th September, 2017Company UpdateDownload PDFDownload XBRL
  Exchange Received Time  09/10/2017 12:18:13         Exchange Disseminated Time   09/10/2017 12:18:21              Time Taken   00:00:08

In compliance with Regulation 13(3) of SEBI (LODR) Regulations, 2015, please find below the statement of investors complaints for the quarter ended 30th September, 2017:

SI.No. Particulars Number
1 Number of complaints pending at the beginning of the quarter Nil
2 Number of complaints received during the quarter 11
3 Number of complaints disposed of during the quarter 11
4 Number of complaints remaining unresolved at the end of the
quarter Nil

26 Sep 2017
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)AGM/EGM 
  Exchange Disseminated Time     26/09/2017 15:06:33
Divis Laboratories Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
 
  Scrutinizer's ReportAGM/EGMDownload PDFDownload XBRL
  Exchange Received Time  26/09/2017 14:40:46         Exchange Disseminated Time   26/09/2017 14:40:51              Time Taken   00:00:05
Pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, details of voting results of 27th Annual General Meeting (AGM) of the Company held on 25th September 2017 at 10.00 a.m. at Global Peace Auditorium, Brahma Kumaris, Shanti Sarovar, Academy for Better World, Gachibowli, Hyderabad - 500 032, are enclosed as per prescribed format. ....

Disclaimer Next >>